{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:59:46Z","timestamp":1790495986091,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007241","name":"Universit\u00e9 Paris-Saclay","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjaopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["BJA Open"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.bjao.2022.100029","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T13:04:22Z","timestamp":1660741462000},"page":"100029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Antinociceptive properties of losmapimod in two acute pain models in rats: behavioural analysis, immunohistochemistry, dose response, and comparison with usual analgesic drugs"],"prefix":"10.1016","volume":"3","author":[{"given":"Micka\u00ebl","family":"Soued","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Hamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouna","family":"Ben Rehouma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Xavier","family":"Mazoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Benhamou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjao.2022.100029_bib1","first-page":"153","article-title":"Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions","volume":"22","author":"Pearson","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bjao.2022.100029_bib2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1152\/physrev.2001.81.2.807","article-title":"Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation","volume":"81","author":"Kyriakis","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bjao.2022.100029_bib3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrd1177","article-title":"p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases","volume":"2","author":"Kumar","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bjao.2022.100029_bib4","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.4049\/jimmunol.0802954","article-title":"Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation","volume":"182","author":"Brambilla","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bjao.2022.100029_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1042\/BJ20100323","article-title":"Mechanisms and functions of p38 MAPK signalling","volume":"429","author":"Cuadrado","year":"2010","journal-title":"Biochem J"},{"key":"10.1016\/j.bjao.2022.100029_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuroscience.2013.01.001","article-title":"Activation of p38 mitogen-activated protein kinase in the dorsal root ganglion contributes to pain hypersensitivity after plantar incision","volume":"234","author":"Mizukoshi","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.bjao.2022.100029_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.pain.2004.09.038","article-title":"Activation of p38 MAPK in primary afferent neurons by noxious stimulation and its involvement in the development of thermal hyperalgesia","volume":"113","author":"Mizushima","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.bjao.2022.100029_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/glia.10308","article-title":"Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury","volume":"45","author":"Tsuda","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.bjao.2022.100029_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharmthera.2010.01.002","article-title":"Chemokines, neuronal-glial interactions, and central processing of neuropathic pain","volume":"126","author":"Gao","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bjao.2022.100029_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainresrev.2008.12.011","article-title":"MAP kinase and pain","volume":"60","author":"Ji","year":"2009","journal-title":"Brain Res Rev"},{"issue":"Suppl 1","key":"10.1016\/j.bjao.2022.100029_bib11","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.pain.2013.06.022","article-title":"Glia and pain: is chronic pain a gliopathy?","volume":"154","author":"Ji","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.bjao.2022.100029_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0006-8993(99)01326-8","article-title":"Acute peripheral inflammation induces moderate glial activation and spinal IL-1beta expression that correlates with pain behavior in the rat","volume":"829","author":"Sweitzer","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.bjao.2022.100029_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0896-6273(02)00908-X","article-title":"p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia","volume":"36","author":"Ji","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.bjao.2022.100029_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/ALN.0b013e318190bc16","article-title":"Activation of p38 mitogen-activated protein kinase in spinal microglia contributes to incision-induced mechanical allodynia","volume":"110","author":"Wen","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bjao.2022.100029_bib15","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1046\/j.1471-4159.2003.01969.x","article-title":"Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing","volume":"86","author":"Svensson","year":"2003","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.bjao.2022.100029_bib16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.pain.2004.07.007","article-title":"Peripheral and central p38 MAPK mediates capsaicin-induced hyperalgesia","volume":"111","author":"Sweitzer","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.bjao.2022.100029_bib17","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1111\/j.1460-9568.2005.04451.x","article-title":"Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia","volume":"22","author":"Hua","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bjao.2022.100029_bib18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/0091270011405496","article-title":"Novel p38\u03b1 mitogen-activated protein kinase inhibitor shows analgesic efficacy in acute postsurgical dental pain","volume":"52","author":"Tong","year":"2012","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.bjao.2022.100029_bib19","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/j.1532-2149.2012.00256.x","article-title":"Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double-blind, placebo-controlled study","volume":"17","author":"Ostenfeld","year":"2013","journal-title":"Eur J Pain"},{"key":"10.1016\/j.bjao.2022.100029_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/AJP.0000000000000122","article-title":"A\u00a0randomized, placebo-controlled trial of the analgesic efficacy and safety of the p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain from lumbosacral radiculopathy","volume":"31","author":"Ostenfeld","year":"2015","journal-title":"Clin J Pain"},{"key":"10.1016\/j.bjao.2022.100029_bib21","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/BOR.0b013e3283378e6f","article-title":"Kinase inhibitors: a new approach to rheumatoid arthritis treatment","volume":"22","author":"Cohen","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.bjao.2022.100029_bib22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/cpdd.190","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of losmapimod in healthy Japanese volunteers","volume":"4","author":"Ino","year":"2015","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.bjao.2022.100029_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.2042-7158.1972.tb08940.x","article-title":"Biological properties of carrageenan","volume":"24","author":"Di Rosa","year":"1972","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.bjao.2022.100029_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A\u00a0new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.bjao.2022.100029_bib25","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/jpet.109.154443","article-title":"Differential effects of p38 mitogen-activated protein kinase and cyclooxygenase 2 inhibitors in a model of cardiovascular disease","volume":"330","author":"Willette","year":"2009","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.bjao.2022.100029_bib26","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/nrd.2017.202","article-title":"Breaking barriers to novel analgesic drug development","volume":"16","author":"Yekkirala","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bjao.2022.100029_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/08941939.2014.998798","article-title":"A\u00a0comparative investigation of the analgesic effects of metamizole and paracetamol in rats","volume":"28","author":"Ince","year":"2015","journal-title":"J\u00a0Invest Surg"},{"key":"10.1016\/j.bjao.2022.100029_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2016.08.006","article-title":"Acute single dose of ketamine relieves mechanical allodynia and consequent depression-like behaviors in a rat model","volume":"631","author":"Zhang","year":"2016","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bjao.2022.100029_bib29","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.pbb.2004.01.018","article-title":"Nefopam potentiates morphine antinociception in allodynia and hyperalgesia in the rat","volume":"77","author":"Girard","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bjao.2022.100029_bib30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0304-3959(95)01441-1","article-title":"Characterization of a rat model of incisional pain","volume":"64","author":"Brennan","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.bjao.2022.100029_bib31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00000542-200603000-00025","article-title":"Opioid-induced hyperalgesia: a qualitative systematic review","volume":"104","author":"Angst","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bjao.2022.100029_bib32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1213\/ANE.0000000000002601","article-title":"Increased hyperalgesia and proinflammatory cytokines in the spinal cord and dorsal root ganglion after surgery and\/or fentanyl administration in rats","volume":"126","author":"Chang","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bjao.2022.100029_bib33","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.neuropharm.2013.12.005","article-title":"Blockade of peripheral P2Y1 receptors prevents the induction of thermal hyperalgesia via modulation of TRPV1 expression in carrageenan-induced inflammatory pain rats: involvement of p38 MAPK phosphorylation in DRGs","volume":"79","author":"Kwon","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bjao.2022.100029_bib34","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/bjp.2008.33","article-title":"Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity","volume":"153","author":"Hu","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bjao.2022.100029_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1213\/ANE.0000000000004033","article-title":"Microglial modulation as a target for chronic pain: from the bench to the bedside and back","volume":"128","author":"Haight","year":"2019","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bjao.2022.100029_bib36","series-title":"Pharmacology","author":"Gaddum","year":"1959"},{"key":"10.1016\/j.bjao.2022.100029_bib37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/24740527.2020.1720502","article-title":"Translational issues in precision medicine in neuropathic pain","volume":"4","author":"Dickenson","year":"2020","journal-title":"Can J Pain"},{"key":"10.1016\/j.bjao.2022.100029_bib38","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1177\/44.10.8813082","article-title":"NeuN: a useful neuronal marker for diagnostic histopathology","volume":"44","author":"Wolf","year":"1996","journal-title":"J\u00a0Histochem Cytochem"},{"key":"10.1016\/j.bjao.2022.100029_bib39","article-title":"Dehydroepiandrosterone prevents H2O2-induced BRL-3A cell oxidative damage through activation of PI3K\/Akt pathways rather than MAPK pathways","volume":"2019","author":"Li","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.bjao.2022.100029_bib40","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbi.2015.10.006","article-title":"Spinal inhibition of p38 MAP kinase reduces inflammatory and neuropathic pain in male but not female mice: sex-dependent microglial signaling in the spinal cord","volume":"55","author":"Taves","year":"2016","journal-title":"Brain Behav Immun"}],"container-title":["BJA Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772609622000284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772609622000284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:02:02Z","timestamp":1762646522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772609622000284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":40,"alternative-id":["S2772609622000284"],"URL":"https:\/\/doi.org\/10.1016\/j.bjao.2022.100029","relation":{},"ISSN":["2772-6096"],"issn-type":[{"value":"2772-6096","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antinociceptive properties of losmapimod in two acute pain models in rats: behavioural analysis, immunohistochemistry, dose response, and comparison with usual analgesic drugs","name":"articletitle","label":"Article Title"},{"value":"BJA Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjao.2022.100029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of British Journal of Anaesthesia.","name":"copyright","label":"Copyright"}],"article-number":"100029"}}